Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
Christian Mueller(Immutep (Germany)), James L. Januzzi(Harvard University), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), John G.F. Cleland(University of Glasgow), Gerasimos Filippatos(National and Kapodistrian University of Athens), Thomas Mueller(University of Cambridge), Mark Richards(National University Health System), Rudolf A. de Boer(Erasmus MC), Nikola Kozhuharov(University of Bern), Kenneth McDonald(University College Dublin), Andrew J.S. Coats(The Heart Research Institute), Marco Metra(Vita-Salute San Raffaele University), Mitja Lainščak, Petar Seferović, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Wouter C. Meijers(University Medical Center Groningen), Alan S. Maisel(San Francisco VA Medical Center), Frank Ruschitzka(Kantonsspital St. Gallen)
Cited by 786
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k